Unknown

Dataset Information

0

Polyphosphates diminish solubility of a globular protein and thereby promote amyloid aggregation.


ABSTRACT: Structural changes of globular proteins and their resultant amyloid aggregation have been associated with various human diseases, such as lysozyme amyloidosis and light-chain amyloidosis. Because many globular proteins can convert into amyloid fibrils in vitro, the mechanisms of amyloid fibril formation have been studied in various experimental systems, but several questions remain unresolved. Here, using several approaches, such as turbidimetry, fluorescence and CD spectroscopy, EM, and isothermal titration calorimetry, we examined the binding of polyphosphates to hen egg-white lysozyme under acidic conditions and observed polyphosphate-induced structural changes of the protein promoting its aggregation. Our data indicate that negatively charged polyphosphates bind to protein molecules with a net positive charge. The polyphosphate-bound, structurally destabilized protein molecules then start assembling into insoluble amorphous aggregates once they pass the solubility limit. We further show that the polyphosphates decrease the solubility limit of the protein and near this limit, the protein molecules are in a labile state and highly prone to converting into amyloid fibrils. Our results explain how polyphosphates affect amorphous aggregation of proteins, how amyloid formation is induced in the presence of polyphosphates, and how polyphosphate chain length is an important factor in amyloid formation.

SUBMITTER: Sasahara K 

PROVIDER: S-EPMC6802520 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Polyphosphates diminish solubility of a globular protein and thereby promote amyloid aggregation.

Sasahara Kenji K   Yamaguchi Keiichi K   So Masatomo M   Goto Yuji Y  

The Journal of biological chemistry 20190822 42


Structural changes of globular proteins and their resultant amyloid aggregation have been associated with various human diseases, such as lysozyme amyloidosis and light-chain amyloidosis. Because many globular proteins can convert into amyloid fibrils <i>in vitro</i>, the mechanisms of amyloid fibril formation have been studied in various experimental systems, but several questions remain unresolved. Here, using several approaches, such as turbidimetry, fluorescence and CD spectroscopy, EM, and  ...[more]

Similar Datasets

| S-EPMC5434662 | biostudies-literature
| S-EPMC4773402 | biostudies-literature
| S-EPMC6800506 | biostudies-literature
| S-EPMC4770091 | biostudies-literature
| S-EPMC7059794 | biostudies-literature
| S-EPMC5614702 | biostudies-literature
| S-EPMC5383009 | biostudies-literature
| S-EPMC5512541 | biostudies-literature
| S-EPMC5684091 | biostudies-literature
| S-EPMC3481199 | biostudies-literature